Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH
6 search results for:

Hyperthermic intraperitoneal chemotherapy 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 22-01-2018 | Ovarian cancer | News | Article

    Hyperthermic intraperitoneal chemotherapy boosts advanced ovarian cancer outcomes

    Women with advanced-stage ovarian cancer derive a significant survival benefit from the addition of hyperthermic intraperitoneal chemotherapy to interval cytoreductive surgery, phase III trial results indicate. Read the linked commentary from Krishnansu Tewari

    Published in:
    N Engl J Med 2018; 378 : 230–240, 293–294
  2. 17-06-2021 | ASCO 2021 | Conference coverage | Article

    Five-year KEYNOTE-045 update confirms pembrolizumab benefit in advanced UC

    Updated results from the phase 3 KEYNOTE-045 trial show that pembrolizumab monotherapy continues to be associated with improved long-term outcomes relative to chemotherapy in advanced urothelial cancer patients who have progressed on platinum-based chemotherapy. This independent news story was supported by an educational grant from Pfizer and Merck Healthcare KGaA, Darmstadt, Germany

    Author:
    Shreeya Nanda
    Published in:
    2021 ASCO Annual Meeting; 4–8 June
  3. 10-10-2019 | Urothelial cancer | News | Article

    Early data look promising for sacituzumab govitecan in metastatic urothelial carcinoma

    Initial results from the phase II TROPHY-U-01 trial confirm the antitumor activity of sacituzumab govitecan in patients with metastatic urothelial carcinoma that has progressed after platinum chemotherapy or checkpoint inhibition.

    Published in:
    ESMO Congress 2019; Barcelona, Spain: 27 September–1 October
  4. 14-06-2018 | Colorectal cancer | ASCO 2018 | Article

    Oxaliplatin HIPEC unnecessary for colorectal peritoneal carcinomatosis patients

    Oxaliplatin-based hyperthermic intraperitoneal chemotherapy after cytoreductive surgery does not improve the survival of colorectal cancer patients with peritoneal carcinomatosis, the PRODIGE 7 investigators report.

    Published in:
    ASCO Annual Meeting 2018; Chicago, Illinois, USA
  5. 26-01-2018 | Krishnansu S Tewari | Article

    Advisory board comment

    Comment on: Hyperthermic intraperitoneal chemotherapy boosts advanced ovarian cancer outcome

    Author:
    Krishnansu Tewari MD
  6. 20-12-2016 | Colorectal cancer | Article

    Surveillance after curative treatment for colorectal cancer

    For such patients, cytoreductive surgery combined with use of perioperative hyperthermic intraperitoneal chemotherapy (HIPEC) can yield promising outcomes, with 5-year survival of around 40% 11, 12, 15, 185, 186, 187 .

    Author:
    Eric P. van der Stok, Manon C. W. Spaander, Dirk J. Grünhagen, Cornelis Verhoef, Ernst J. Kuipers
  • 1

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.